These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3169679

  • 21. Cumulative hemodynamic response to short-term treatment with flosequinan (BTS 49465), a new direct-acting vasodilator drug, in severe chronic congestive heart failure.
    Kessler PD, Packer M, Medina N, Yushak M.
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):6-11. PubMed ID: 2459536
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Acute and chronic effects of flosequinan on resting and exercise haemodynamics in congestive heart failure.
    Thomas P, O'Gorman DJ, Sheridan DJ.
    Br J Clin Pharmacol; 1993 Dec; 36(6):539-46. PubMed ID: 12959270
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 28. [Vasodilator treatment of left ventricular insufficiency in the acute stage of myocardial infarction].
    Fauvel JM, Donzeau JP, Bounhoure JP, Bernadet P, Calazel P.
    Arch Mal Coeur Vaiss; 1977 Aug; 70(8):825-32. PubMed ID: 409363
    [Abstract] [Full Text] [Related]

  • 29. Acute effects of flosequinan (BTS 49465) in untreated moderate to severe hypertension.
    Janssen MC, Smits P, Reyenga J, Thien T.
    J Hum Hypertens; 1995 May; 9(5):363-8. PubMed ID: 7623374
    [Abstract] [Full Text] [Related]

  • 30. [Hemodynamic evaluation of cardiac insufficiency in the acute stage of myocardial infarct].
    Bachour G, Bender F, Hochrein H.
    Z Kardiol; 1975 Sep; 64(9):841-50. PubMed ID: 1221662
    [Abstract] [Full Text] [Related]

  • 31. The central haemodynamic effects of a single intravenous dose of flosequinan in patients with severe heart failure.
    Markus H, Cowley AJ.
    Eur J Clin Pharmacol; 1991 Sep; 40(6):535-8. PubMed ID: 1884731
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of chronic cardiac failure with cadralazine. Short- and medium-term results].
    Gibelin P, Lloret JL, Drici M, Leborgne L, Camous JP, Mélia P, Morand P.
    Arch Mal Coeur Vaiss; 1987 Feb; 80(2):199-205. PubMed ID: 3107506
    [Abstract] [Full Text] [Related]

  • 33. [Hemodynamic effects of enalapril in patients with non-complicated acute myocardial infarct].
    Ferrario M, Previtali M, Poli A, Lanzarini L, Tortorici M, Mussini A, Montemartini C.
    G Ital Cardiol; 1992 Dec; 22(12):1389-95. PubMed ID: 1294422
    [Abstract] [Full Text] [Related]

  • 34. Acute and long-term effects of flosequinan in patients with chronic cardiac failure.
    Marchionni N, Moschi G, Di Bari M, Burgisser C, Fumagalli S, Boncinelli L, Tarantini F, Ferrucci L.
    Am Heart J; 1993 Jul; 126(1):147-54. PubMed ID: 8322657
    [Abstract] [Full Text] [Related]

  • 35. [Peroral nitrate therapy in severe cardiac insufficiency following acute myocardial infarct].
    Bertel O, Baitsch G, Elsässer S, Ritz R, Burkart F.
    Schweiz Med Wochenschr; 1978 Nov 04; 108(44):1735-7. PubMed ID: 102029
    [Abstract] [Full Text] [Related]

  • 36. Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan.
    Moe GW, Rouleau JL, Charbonneau L, Proulx G, Arnold JM, Hall C, de Champlain J, Barr A, Sirois P, Packer M.
    Am Heart J; 2000 Apr 04; 139(4):587-95. PubMed ID: 10740139
    [Abstract] [Full Text] [Related]

  • 37. Flosequinan: a vasodilator with positive inotropic activity.
    Corin WJ, Monrad ES, Strom JA, Giustino S, Sonnenblick ES, LeJemtel T.
    Am Heart J; 1991 Feb 04; 121(2 Pt 1):537-40. PubMed ID: 1990760
    [Abstract] [Full Text] [Related]

  • 38. Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.
    Cowley AJ, Wynne RD, Stainer K, Fullwood L, Rowley JM, Hampton JR.
    BMJ; 1988 Jul 16; 297(6642):169-73. PubMed ID: 3044507
    [Abstract] [Full Text] [Related]

  • 39. [The hemodynamic effect of Capoten in patients with myocardial infarct complicated by heart failure].
    Iaremenko OB, Netiazhenko VZ, Emchenko IR, Kurochko VB.
    Vrach Delo; 1989 Nov 16; (11):44-7. PubMed ID: 2692289
    [Abstract] [Full Text] [Related]

  • 40. Clinical efficacy of flosequinan in heart failure.
    Cowley AJ.
    Am Heart J; 1991 Mar 16; 121(3 Pt 1):983-8. PubMed ID: 2000777
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.